Found: 18
Select item for more details and to access through your institution.
Effectiveness and Safety of OnabotulinumtoxinA in Adolescent Patients with Chronic Migraine.
- Published in:
- Toxins, 2024, v. 16, n. 5, p. 221, doi. 10.3390/toxins16050221
- By:
- Publication type:
- Article
The relationship of headache as a symptom to COVID‐19 survival: A systematic review and meta‐analysis of survival of 43,169 inpatients with COVID‐19.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 8, p. 1019, doi. 10.1111/head.14376
- By:
- Publication type:
- Article
The impact of a digital platform on migraine patient‐centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 9, p. 1403, doi. 10.1111/head.14225
- By:
- Publication type:
- Article
Cluster Headache Genomewide Association Study and Meta‐Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor.
- Published in:
- Annals of Neurology, 2023, v. 94, n. 4, p. 713, doi. 10.1002/ana.26743
- By:
- Publication type:
- Article
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 5, p. 846, doi. 10.1002/ana.26472
- By:
- Publication type:
- Article
The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 10, p. 3789, doi. 10.1007/s00415-021-10523-8
- By:
- Publication type:
- Article
Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01289-5
- By:
- Publication type:
- Article
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01772-9
- By:
- Publication type:
- Article
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01727-0
- By:
- Publication type:
- Article
Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01618-w
- By:
- Publication type:
- Article
In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01366-9
- By:
- Publication type:
- Article
Quantifying sensory thresholds along the migraine cycle: An exploratory longitudinal study.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024241230279
- By:
- Publication type:
- Article
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies.
- Published in:
- Cephalalgia, 2024, v. 44, n. 2, p. 1, doi. 10.1177/03331024231222923
- By:
- Publication type:
- Article
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients.
- Published in:
- Cephalalgia, 2022, v. 42, n. 8, p. 804, doi. 10.1177/03331024211068074
- By:
- Publication type:
- Article
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 186, doi. 10.1177/03331024211040467
- By:
- Publication type:
- Article
Migraine worsening after COVID‐19 and COVID‐19 vaccination: Are we facing a nocebo effect?
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 12, p. 3877, doi. 10.1111/ene.16058
- By:
- Publication type:
- Article
Patterns of response to anti‐calcitonin gene‐related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcome.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 7, p. 1937, doi. 10.1111/ene.15816
- By:
- Publication type:
- Article
Partial and nonresponders to onabotulinumtoxinA can benefit from anti‐CGRP monoclonal antibodies preventive treatment: A real‐world evidence study.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 7, p. 2378, doi. 10.1111/ene.14828
- By:
- Publication type:
- Article